Intellia Therapeutics Shares Rise as FDA Grants Priority Review to Lonvo-z
Intellia Therapeutics (NASDAQ:NTLA) shares rose 8% on Tuesday after the U. S.
Pharma & Biotech
Drug approvals, clinical trials, and news from the pharmaceutical and biotech industry.
Oil Prices Near $100 on Middle East Tensions
U.S. Energy Stocks Rise Premarket as Brent Approaches $100
Shares of major U. S. energy companies moved higher in premarket trading on Tuesday as crude oil prices extended their gains amid concerns about potential disruption to Middle East energy supplies.
Novartis Heart Drug Fails Late-Stage Trial
Novo Nordisk Mixed Clinical Results
Wegovy’s Latest Trial Gives Novo Nordisk (NVO) Another Potential Growth Catalyst
Novo Nordisk A/S (NYSE:NVO) has delivered encouraging late-stage data for Wegovy in younger children, with its STEP Young trial showing that 40.4% of children aged 6 to under 12 were no longer classified as having obesity after 68 weeks of semaglutide treatment, compared with none in the placebo group. The trial met its primary endpoint, […]
Biotech Stocks Slide on Clinical Setbacks
Dividend Kings Outperform Defensive ETFs
JEPI Is an Income Machine—But These 3 Dividend Stocks Don’t Cap Your Upside
JEPI's monthly paycheck looks irresistible until you see exactly what the fund surrenders to produce it. Three Dividend Kings quietly sidestep that tradeoff, and the difference compounds in ways most income investors never stop to calculate.
